Presentations and other literature

Hepatocellular Carcinoma

Title PRECISION V data
Presented Cardiovascular and Interventional Radiological Society of Europe (CIRSE) 2008, Satellite Symposium
Date 15 September 2008
Presentations Data from the latest Drug-Eluting Bead Clinical Trial, PRECISION V; Prof J Lammer
 
 
 
  PRECISION V Safety; Prof A Watkinson
  Central Imaging Review and Efficacy Data; Prof R Lencioni
  Webcast at CIRSE 2008:
Data from the latest Drug-Eluting Bead Clinical Trial, PRECISION V; Prof J Lammer
  PRECISION V Safety; Prof A Watkinson
Central Imaging Review and Efficacy Data; Prof R Lencioni
To obtain a copy of any PRECISION V presentation, please send a request to marketing@biocompatibles.com

 

Title Drug-Eluting Beads:  A Novel  Neoadjuvant Treatment in Colorectal Metastases and Primary Liver Cancer
Presented ESSO 2008, The Hague, The Netherlands
Date 12 September 2008
Presentations Concentration of doxorubicin in tissue after chemoembolisation with DC Bead, pre-clinical and clinical data
Dr Julien Namur; Department of Neuroradiology, Hopital Lariboisiere, Paris, France
  Preliminary results from an open registry evaluating Drug-Eluting Beads in primary and metastatic liver tumours
Dr Robert Martin; Associate Professor of Surgery, Division of Surgical Oncology, University of Louisville, Kentucky, USA
Title The histological and clinical impact of the treatment of HCC patients eligible for surgery with intra-arterial, doxorubicin Drug-Eluting Beads
Presented International Liver Cancer Association (ILCA), Chicago, Illinois, USA
Date 5 September 2008, 11.15-12.30, The Fairmont Chicago Hotel
Presentations Chemoembolization with doxorubicin-eluting beads for HCC in surgical and non-surgical candidates, with histological evidence of efficiency in transplanted patients
Dr Marty Sellers; Director, Liver Cancer Services Piedmont Hospital, Atlanta, USA  
  International hepatic arterial embolization registry for hepatocellular cancer:  surgical downstaging and safety
Dr Robert Martin; Associate Professor of Surgery, Division of Surgical Oncology. University of Louisville, Kentucky, USA
Presented WCIO & Best of ASCO 2008
Date 22 - 25 June 2008
Presenter Dr Peter Stratford
Presentations Biology and Advances in Drug-Eluting Beads  
Title Product Assessment and Expanded Opportunities in Embolotherapy
Presented GEST 2008 Satellite Symposium
Date 7 June 2008, Barcelona, Spain
Chairperson Professor Anthony Watkinson, The Royal Devon and Exeter Hospital, UK
Presentations Chemo-embolisation with DC Bead:  overview of the data available in primary and non-primary liver tumours
Dr Thierry De Baere, Institut de Cancerologie Gustave Roussy, Villejuif, France
Title Infarction End Point in Bland Embolisation and Drug-Eluting Beads: latest updates
Presented ET/ECIO Satellite Symposium
Date 10 April 2008, Florence, Italy
Chairman Professor Alban DENYS, Lausanne, Switzerland
Presentations TACE with DC Bead as a pre-transplant treatment for HCC:  results with anatomopathological data
Professor Pierre GOFFETTE, Cliniques Universitaires de St Luc, Brussels, Belgium
  Interim Analysis of DC/LC Bead Open Surgical Registry in Primary and Metastatic Liver Tumours
Dr Robert MARTIN, University of Kentucky, Lexington, USA
Title Innovations in Chemo Embolization
Presented SIR Dinner Symposium
Date 18 March 2008, Grand Hyatt Washington, Washington, D.C., USA
Chairman Professor Alban DENYS, Lausanne, Switzerland
Presentations Interim Analysis of Multi-Institutional LC Bead Registry in Primary and Metastatic Hepatic Tumors
Dr Robert Martin
Title Drug-Eluting Beads:  A New Therapy for Hepatic Tumours - Clinical and Pharmaceutical Assessment
Presented A satellite symposium at the 13th Congress of the European Association of Hospital Pharmacists (EAHP)
Date 27 February 2008, MECC, Maastricht, The Netherlands
Chair Mr Eugene Hardy
Presentations Drug-Eluting Beads in the management of hepatocellular carcinoma prior to liver transplantation,
Professor Pierre Goffette 
  Drug-Eluting Beads with doxorubicin:  Stability assessment, Professor Jean-Daniel Hecq
  Combination drug-device products - a challenge or opportunity for the pharmacy?,
Mr Ron Pate
Title ISET
Date 20 - 24 January 2008, Florida, USA
Presentations  Randomized trial of Drug-Eluting Bead embolization vs TACE in HCC
J Lammer, Department of Cardiovascular and Interventional Radiology, Medical University of Vienna, Austria
Title Interventional News Educational Supplement (report on CIRSE and ILCA 2007 satellite symposia)

CIRSE: 'The future prospects in oncology treatment using Drug-Eluting Beads'

ILCA: 'TACE in HCC: a multi-disciplinary overview'
Published Interventional News
Date December 2007
Author Biba Medical
Title TACE in HCC: A Multi-Disciplinary Overview
Preented International Liver Cancer Association (ILCA) Congress - Biocompatibles Symposium
Date October 2007
Chair Professor J Bruix
 Presentations Device Selection and Delivery Technique, Professor R Lencioni
  Oncology Perspectives on the Management of Liver Cancer,             Professor M Ducreux
Title Interventional Oncology: Future Horizons with Drug-Eluting Beads
Preented Cardiovascular and Interventional Radiology Society of Europe (CIRSE) Congress - Biocompatibles / Terumo Symposium
Date September 2007
Chair Professor A Watkinson
Presenrations Drug-Eluting Bead Enhanced-RFA in Hepatocellular Carcinoma, Professor R Lencioni
  PRECISION TACE, of Hepatocellular Carcinoma with Drug-Eluting Beads:  62-Patient Registry, Professor K Malagari
Title Doxorubicin eluting Beads:  Efficacy and Safety in the treatment of HCC
Preented American Hepato Pancreato Biliary Association Meeting (AHPBA)
Date April 2007
Author Imagawa, D
Title The future of interventional oncology
Preented Interventional News, Educational Supplement
Date November 2006
Author Vogl T, Lencioni R (CIRSE 2006)
Title Review of Abstracts and presentations on Drug-Eluting Beads
Preented Interventional News, Educational Supplement
Date November 2006
Author DeBaere T, Stadler A, Bruix J, Malagari K, Llovet J M, Pelage J P
Title Drug loaded microspheres for precise transarterial chemoembolisation of hypervascular liver lesions
Preented Interventional News, Educational Supplement
Date November 2006
Author Wiskirchen J, Tepe G, Pereira P
Title Interventional Oncology:  Drug Eluting Beads, the future
Preented CIRSE 2006 symposium
Date September 2006
Authors Introduction (Lammer J)
  Combined Precision TACE and RF ablation in hepatocellular carcinoma treatment  (Lencioni R) 
  Questions and Answers (Vogl  Tand Lencioni R)
View CIRSE 2006 Symposium recording
Title Transcatheter Arterial Chemoembolisation (TACE) for HCC - Classic Concepts and Future Evolution
Journal European Oncological Disease
Date 2006
Authors Liapi E, Geschwind J
View Geschwind Touch Briefings Article 2006  (390k)


Advanced Search

 

© 2010 Biocompatibles UK Ltd - All rights reserved - Site map - Terms & conditions - Accessiblity - Help - Glossary